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Abstract
Background: In Vietnam, like many countries in Southeast Asia, the commonly used approach of center-based
compulsory drug treatment (CCT) has been criticized on human rights ground. Meanwhile, community-based
voluntary methadone maintenance treatment (MMT) has been implemented for nearly a decade with promising
results. Reform-minded leaders have been seeking empirical evidence of the costs and effectiveness associated with
these two main treatment modalities. Conducting evaluations of these treatments, especially where randomization
is not ethical, presents challenges. The aim of this paper is to discuss political challenges and methodological issues
when conducting cost-effectiveness studies within the context of a non-democratic Southeast Asian country.
Methods: A retrospective analysis of the political and scientific challenges that were experienced in the study design,
sample size determination, government approval and ethics approvals, participant recruitment, data collection, and
determination of sources, and quantification of cost and effectiveness data was undertaken. As a consequence of the
non-randomized design, analysis of patient characteristics for both treatment types was undertaken to identify the
magnitude of baseline group differences. Concordance between self-reported heroin use and urine drug testing was
undertaken to determine the reliability of self-report data in a politically challenging environment.
Results: We demonstrate that conducting research around compulsory treatment in a non-democratic society is
feasible, yet it is politically challenging and requires navigation between science and politics. We also demonstrate that
engagement with the government decision makers in the research conception, implementation, and dissemination of
the results increases the likelihood of research evidence being considered for change in a contentious drug policy area.
Conclusions: Local empirical evidence on the comparative cost-effectiveness of CCT and MMT in a Southeast Asian
setting is critical to consideration of more holistic, humane, and effective drug-dependence treatment approaches, but
the garnering of such evidence is very challenging.
Keywords: Compulsory treatment, Heroin use, Methadone treatment, Southeast Asia, Cost-effectiveness
Background
The problem of drug abuse and trafficking in Vietnam is
long-standing, primarily due to its proximity to the
“Golden Triangle”, the opium-producing region border-
ing Myanmar, Thailand, and Laos. The economic de-
regulation (known as Doi Moi) of Vietnam in 1986
enabled the introduction of market-oriented policies that
facilitated the rapid growth of the economy and
subsequent changes in lifestyles. One such change, espe-
cially in urban areas, was an increase in illicit drug use
[1, 2]. The official number of people reported as
dependent on illicit drugs increased quickly from 50,000
in 1995 to 150,000 in 2011 and 204,000 in 2015 [3].
Heroin has remained the primary drug of choice (84.7%)
primarily via injection, followed by methamphetamine
(5%), cannabis (1.3%) and pharmaceuticals (0.5%) [3].
Like many countries in Asia (11 countries), center-
based compulsory treatment (CCT) is a common ap-
proach for resolving illicit drug use problems in Vietnam
[4–7]. These countries (including Cambodia, China,
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Indonesia, Malaysia, Philippines, Thailand, and Vietnam)
have endorsed policies that force people who use illicit
drugs into some form of compulsory rehabilitation [8].
Largely based on a philosophy of “social reeducation”,
compulsory rehabilitation gained momentum during the
1990s with the construction of large-scale centers in
Malaysia, China, and Vietnam [9, 10]. This approach
was imported by neighboring countries with an esti-
mated 2 million people placed in compulsory centers in
China and South East Asia in 2006 [11].
Compulsory rehabilitation centers have been criticized
by the UN and human rights organizations for a variety
of human rights abuses including involuntary indefinite
detention, physical abuse, torture, and denial of or inad-
equate medical care [9, 12]. The first compulsory re-
habilitation center in Vietnam was built in 1993 and by
the end of 2015 there were 121 centers nation-wide with
the placement of approximately 45,000 people at a time
[3]. During the last two decades, the Vietnamese govern-
ment has invested approximately US$47 million/year
into this approach [13]. Yet, whether the centers are suc-
cessful remains under debate [4, 14, 15] .People who use
illicit drugs can be confined in the center for up to
2 years [4]. These centers are not part of the criminal
justice system and their detainees have not necessarily
been convicted of any crime [16].
The burden of illicit drug use on the health-care system
is considerable. As a consequence of shifts in the route of
heroin administration in most East and Southeast Asia
countries from smoking to injecting and the associated
sharing of injecting equipment, HIV prevalence among
people who inject drugs dramatically rose. In Vietnam,
injecting drug use accounts for two-thirds of all HIV cases
[13]. The alarming twin epidemic of HIV and injection
drug use attracted international donor agencies’ interest
due to concerns about the potential for a more generalized
epidemic. Considerable investment from international do-
nors resulted in large-scale MMT programs as well as
needle and syringe programs in many Asian countries,
notably China, Malaysia and Vietnam [11]. In Vietnam, by
March 2016, a total of 44,479 people had received MMT
(27.3% of 163,000 dependent heroin users) [17]. However,
the primary approach funded by the Vietnamese govern-
ment for dealing with illicit drug use remains center-based
compulsory rehabilitation (CCT).
Two recent events changed the landscape of drug pol-
icy in Vietnam in different but interrelated ways. The
first was the release of a Human Rights Watch report
into labor abuse of detainees in CCT centers in the
South of Vietnam [18]. The second was the Vietnamese
economy attaining middle-income status economy in
2010 [19], and hence no longer receiving international
funding priority. Reform-minded Vietnamese policy
makers were challenged by the reported limited success
of the CCT centers approach [20] and the increasing
number of dependent illicit drug users. In response, they
reached out to international agencies for technical assist-
ance to inform their investment mix. This included the
provision of scientific evidence from economic evalua-
tions of drug dependence treatment alternatives.
While considerable evidence of effectiveness [21, 22]
and cost-effectiveness of MMT [23] exists, there was a
lack of evidence regarding CCT, particularly in the East
and Southeast Asian context. To date, only one study
had been conducted in South East Asia. The study [24]
conducted in Thailand evaluated the effectiveness of the
Therapeutic Communities Program delivered in closed
settings. While it found a large reduction in illicit drug
use over 6 months, there was no control group and the
highly significant contextual factors (the study was con-
ducted from 2005 to 2007, only 2 years after the com-
mencement of the Thailand war on drugs) may account
for the results [25].
To address this lack of evidence an, evaluation of the
relative effectiveness (as measured by heroin use, drug-
free days, illegal behaviors, overdose, blood-borne virus
risk behaviors and monthly drug spending) and cost-
effectiveness (as measured by the cost to achieve “drug-
free days” over three years, and the cost to achieve the
proportion of people abstinence from illicit drug use) of
CCT compared to MMT was undertaken in Vietnam (see
[26]). The results of the cost-effectiveness study are re-
ported elsewhere [26] where MMT was found to be super-
ior to CCT in terms of both cost and effectiveness. This
paper discusses the research challenges and solutions, pro-
vides the political context, and demonstrates the ability to
undertake such research in a non-democratic society.
Methods
A retrospective analysis of the political and scientific chal-
lenges experienced in the study design, study approval,
data collection, ethics approvals, and analytic strategy was
undertaken. Specifically, a thorough review of all versions
of the study protocol and questionnaires, minutes of
meetings held with the government of Hai Phong City,
and all versions of the study timeline and participant re-
cruitment timelines were undertaken. Due to the non-
randomized design and to determine the magnitude of
baseline differences, a comparison of participant charac-
teristics for both treatment arms was undertaken. Con-
cordance between self-reported heroin use and urine drug
testing was examined to determine reliablity of self report
research data in a politically challenging environment.
Results
The results are presented chronologicaly, in terms of the
issues we confronted, commencing with determining the
most appropriate study design, followed by the study
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setting selection, the sample size, obtaining ethics ap-
provals, strategizing participant recruitment, data collec-
tion methods, and sources and quantification of data (for
both costs and outcomes/effectiveness).
Designing the study
In an ideal world, a cost-effectiveness study would entail
a randomized design, where participants are randomly
allocated to one of two groups: CCT and MMT. How-
ever, it was not ethical to randomize people to CCT - an
intervention which violates human rights. It would also
not have been practical to randomize participants inas-
much as those randomized to CCT would most likely
withdraw from the study. In this context, a quasi-
experimental design was the only feasible alternative but
this posed further challenges in that there could poten-
tially be significant differences between the two groups
because of the lack of random assignment.
Table 1 provides the participants’ demographic charac-
teristics by treatment group. One hundred percent of
the participants in both groups were male because all
three CCT centers involved in this study were for male
illicit drug users. The CCT group was significantly youn-
ger (mean = 33.26 vs 37.32 years), more likely to be sin-
gle (51.69 vs 43.49%), more likely to be employed (76.45
vs 66.67%) and had higher legal monthly income (3.00
million VND versus 1.50 million VND). There were no
statistically significant differences between the two
groups in education with 39.90% of CCT participants
and 46.09% of MMT participants having finished high
school (12 years of education) at minimum.
Table 2 summarizes participants’ drug use history and
behavioral characteristics by treatment group. Both
groups started to use drugs in their early 20s. The CCT
group had a higher proportion commencing with heroin
as the first drug used (85.58 vs 80.73%) compared to the
MMT group but their median daily use frequency was
lower (three times a day vs four times a day) and they
had been using drugs for fewer years (11.01 vs
13.17 years). Three months prior to commencing either
MMT or CCT, the proportion of people who used her-
oin daily was not statistically different between two
groups (CCT = 97.50%; MMT = 99.96%). From the com-
mencement of drug use until treatment entry, the CCT
group spent less money on drugs on a monthly basis
(4.55 million dongs (~US$213) vs 6.05 million dongs
(~US$290)), which is consistent with using less
frequently.
A smaller proportion of the CCT group reported hav-
ing ever injected heroin (66.43 vs 82.55%). However, the
CCT group were more likely to be poly drug users
(50.48 vs 28.91%), with 28.30% of CCT participants and
11.60% of MMT participants also using methampheta-
mine. Among those who were poly drug users, the CCT
group used a higher number of drug classes (3 vs 2). In
terms of drug dependence treatment history, CCT par-
ticipants were less likely to have sought treatment (78.77
vs 96.61%) and, for those who did, the median number
of treatment episodes was fewer (2 vs 5). CCT partici-
pants were less likely to have previously been in CCT
centers (37.98 vs 49.74%) and less likely to have under-
gone home-based detoxification (66.70 vs 84.40%). Even
though there was no statistically significant differences
in the proportions of people who reported ever commit-
ting illegal behaviors (CCT = 35.20% and MMT=
30.30%), a significantly higher proportion of MMT par-
ticipants had ever been to prison (26.30 vs 16.35%).
There was no statistical difference between the two
Table 1 Participants’ demographic characteristics by treatment group
CCT (n = 208) MMT (n = 384) Test result and P value
Male (%) 100 100 n/a
Mean age (SD) 33.26 (7.60) 37.32(8.23) t(590) = -5.624; p < 0.001
Marital status (%)





Unemployed 23.56 33.33 X2(2) = 11.46; P = 0.003
Full-time 17.31 21.35
Part-time (casual work) 59.14 45.32
Average legal monthly income
(median and range)
3.00 million (0.80–15.00 million) 1.50 million (0–35.00 million) U = 28,617; p < 0.001
Education (%)
≥High school 39.90 46.09 X2(1) = 1.95; p = 0.16
<High school (year 12) 60.10 53.91
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groups (CCT = 18.50% and MMT = 12.10%) in the pro-
portion of participants who had experienced a drug
overdose.
Because this study was an observational, non-
randomized study, baseline characteristic differences
between groups were not unexpected. Overall, CCT par-
ticipants appeared to be less dependent on illicit drugs
compared to MMT participants at baseline. This poten-
tially biased the study in favour of CCT over MMT.
Statistical techniques that accommodated baseline differ-
ences were essential. This entailed the use of mixed
effects regression models with covariance analysis ad-
justments (see details in [26]).
The second design consideration was the time and avail-
able resources for the study. Again, in an ideal world, both
groups would be followed prospectively, with similar time-
frames (such as data collection at admission, and then at
subsequent follow-up points). However, a comprehensive
study of MMT had already been undertaken in Vietnam,
which provided a potential sampling frame for the MMT
arm of this study [27]. Commencing a new MMT cohort
would require nearly double the funding and two add-
itional years of research implementation.
The final study design built on the absence of
randomization and the investment that had been made
in the previous MMT study. The result was a combined
retrospective and prospective quasi-experimental cohort
study with five time-points; baseline (B), 2 years after
treatment commencement (T1), then 3 months (T2),
6 months (T3) and 12 months (T4) prospective follow-
up. The MMT participant group was drawn from the
384 MMT participants from the previous study at their
24-month post-treatment interview. They were then in-
vited to participate in the current study. The CCT group
was recruited at point of exit from the CCT centers (that
is, after 2 years in the program) which resulted in a no-
tional equalization between the two groups in terms of
time since intervention commencement. The results are
available at [26].
Study setting
An informed decision needed to be made when deter-
mining potential research settings. In an ideal world, the
study sites would be randomly selected, however prag-
matic practical considerations ensuring feasibility meant
that a single city was selected: Hai Phong City. Hai
Phong City is one of only two cities in Vietnam where
both CCT and MMT programs were well-established
with standardized policies and procedures. Second, it
was the only city where the political leadership was
Table 2 Participants’ drug use history and behavioral characteristics by treatment group
CCT (n = 208) MMT (n = 384) Test result and P value
Mean age of first intoxication (SD) 22.35 (5.79) 23.22 (6.42) t(590) = -1.68; p = 0.09
% drugs of first intoxication
Heroin 85.58 80.73 X2(2) = 7.26; p = 0.03
Opium 10.58 16.41
Other drugs 4.81 2.34
Mean number of years used (SD) 11.01 (6.22) 13.17 (4.63) t(590) = -5.08; p < 0.001
Ever reported daily heroin use (%) 97.54 99.96 X2(1) = 3.57; p = 0.06
Median heroin use frequency of those
who used every day (range)
3 (0–20) 4 (0–18) U = 64,077; p < 0.001
Median monthly drug spending (range) 4.55 mil VND (0–84 mil) 6.20 mil VND (0–225 mil) U = 60,171; p < 0.001
% heroin injection ever 66.43 82.55 X2(1) = 30.79; p < 0.001
% poly drug use evera 50.48 28.91 X2(1) = 29.99; p < 0.001
Mean number of drug classes used (SD)
of those who were poly users
3 (1.25) 2 (0.82) t(214) = 4.69; p < 0.001
% ever sought drug dependence treatment 80.77 96.61 X2(1) = 55.14; p < 0.001
Median number of treatment episodes (range)b 2 (1–50) 5 (1–40) U = 49,581; p < 0.001
% ever been to CCT centers 37.98 49.74 X2(1) = 8.46; p = 0.004
% ever home detoxed 66.70 84.40 X2(1) = 27.67; p < 0.001
% ever committed illegal behaviors 35.20 30.30 X2(1) = 2.35; p = 0.13
% ever been to prison 16.35 26.30 X2(1) = 7.59; p = 0.006
% overdose incident ever 18.75 12.10 X2(1) = 3.49; p = 0.06
aMethamphetamine second drug of choice 28.30% for CCT and 11.60% for MMT
bFor those who ever sought treatment
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willing to work with international organizations to re-
view their drug dependence treatment system so as to
improve effectiveness and efficiency. Third, FHI360, a
US-based non-governmental organization and one of
the three institutions involved in facilitating this re-
search, had already developed a long-term relationship
with the Hai Phong government leaders through the
funding and implementation of a comprehensive HIV
prevention and drug dependence treatment program in-
cluding MMT.
The ultimate goal of conducting this research was to
generate evidence that would support a dialogue for drug
policy change. Therefore, engaging policy-makers and
government leaders of Hai Phong City in the entire
process of conceptualization, conduct, interpretation, and
dissemination of the research was critical. As such, a series
of consultations between the research team and the Hai
Phong city government leaders and relevant departments
took place in early 2012. Despite the long-term relation-
ship and trust between FHI360 and Hai Phong City gov-
ernment, getting political approval for this study was not
an easy task; it took nearly 2 years to obtain approval. The
political support of the local government was critical for
permission to interview CCT participants and for access
to CCT centers’ costing data. Most importantly, the polit-
ical leadership expressed a commitment to review the
findings of the study, engage in discussions around those
findings and consider possible change to resource alloca-
tion taking the study findings into account.
CCT has existed in Hai Phong City (a coastal city in
Northern Vietnam) since 1991. Significant investment
has been made by the city government to the three CCT
centers with a combined capacity of approximately 2500
people (out of an estimated 8000 people dependent on
illicit drugs). In the community, if someone is identified
as using illicit drugs, they will be encouraged to undergo
community-based detoxification treatment. If they fail
to stop using drugs after several attempts, they are
sent to a CCT center for a period of two years.
People can also be arrested during ‘special cleaning
up’ occasions and if their urine drug test is positive
they may be sent to the CCT centers. In the centers,
the “rehabilitation” strategies focus on moral teaching,
basic health care services, “cold turkey” detoxification,
and forced labor work [28].
MMT was first piloted in Hai Phong City (three
clinics) and Ho Chi Minh City in 2008 and from 2011
was endorsed by the government for rapid expansion
nation-wide. In Vietnam, MMT requires daily supervised
dosing by clinic staff. As part of the treatment protocol,
random opiate urine drug testing occurs on a monthly
basis. If the patient continues to use opiates while in
MMT treatment, he/she is provided with relapse preven-
tion counseling services.
Sample size
Determining the appropriate sample size for this study
needed to address three aspects: 1) the lack of previous
research on CCT; 2) the non-randomized design and; 3)
potential loss to follow-up. The primary outcome meas-
ure used in the power analysis was the estimated propor-
tion of people to be heroin abstinent at the final time-
point (T4). The calculation used an alpha of 0.05, beta
of 0.20 (power 80%) and an estimated proportion of suc-
cessful treatment (heroin-free) of 20% at 12 months after
being released from CCT centers (T4).This estimate had
been reported by the governments of many provinces/
cities in Vietnam, using administrative data. To be con-
servative, we assumed that the CCT in Hai Phong City
was more effective compared to the rest of Vietnam with
a success rate of 42% at 12 months following release.
This assumption was based on the higher level of invest-
ment in facilities and human resources. For MMT treat-
ment, the 2009 MMT cohort study reported 85.4% of
the MMT participants who remained in treatment were
heroin abstinent at 12 months. The power analysis as-
sumed that the proportion of MMT participants who
were free of illicit drug use would be 62.4% if the data
analysis included both missing and censored data. These
assumptions determined a minimum sample size of 136
per group which was increased to 186 given an esti-
mated 30% loss to follow-up. Due to the non-
randomized study design, baseline group differences
were expected and therefore the final sample size of 208
(for each group) was determined.
Additional consideration was given to the appropriate
selection of the MMT sample: a choice between the 384
MMT participants at T1 or only the 314 who consented
to participate in the follow-up time periods (T2). A deci-
sion was made to select the 384 people who were inter-
viewed at 2-year post-treatment as the starting sample.
This strategy aimed to equalize the starting samples of
both the CCT and MMT groups to the number at the
end of 2-year post treatment. This potentially biases
against MMT, inasmuch as there are no follow-up data
for the 70 MMT participants (384–314) who were un-
able to be contacted. Their outcome data were then im-
puted using a worst case scenario assumption.
Ethics approvals
Ethics approvals were required and granted by three in-
stitutions: the University of New South Wales
(#HC12259, dated 1 August 2012), Hanoi Medical Uni-
versity (#106/HMU IRB dated 2 October 2012), and
FHI360 Headquarters in NC, the USA ([408418-
1]#10389, dated 13 December 2012). It took between
three and five months for each approval. Each ethics ap-
plication required that all participant information, con-
sent forms and questionnaires be provided in both
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English and Vietnamese. This required fluency in both
English and Vietnamese, and competency in the tech-
nical content. In addition, the research proposal, the Par-
ticipant Information Statement, Consent Form and
questionnaires were submitted to the Local Review
Committee which comprised the Hai Phong City local
Government agencies (#4219/UBND-VX dated 17 June
2013). The Participant Information Statement/Consent
Form included one section on consent from the partici-
pants for their data to be published.
The interactions with the Hai Phong City local Govern-
ment agencies were critical for two reasons. Firstly, the
Hai Phong city government was sensitive about endorsing
an international organization conducting research involv-
ing CCT centers, particularly when this approach had
been criticized openly both at national and international
fora by human rights organizations. Without the oppor-
tunity to review the study documents, the Hai Phong city
government would not have been confident to endorse
the research. Secondly, engagement of the policy-makers
who could potentially use the study results to formulate
actions increases the likelihood of those findings being ap-
plied. There were some concerns that these interactions
around the study formulation would jeopardize the object-
ivity of the study. Therefore, one strategy employed was to
facilitate the establishment of a Local Review Committee
such that it comprised a full range of stakeholders includ-
ing the health department, police department and labor
and social affairs departments. Clear roles, responsibilities
and accountabilities were defined whereby the researchers,
not the committee, were responsible for the final product.
This arrangement of roles and responsibilities enabled the
government staff to function in their role while contribut-
ing to the quality of the final product.
Due to the concern about the potential reporting of hu-
man rights violations as well as behaviors of the CCT par-
ticipants while in the CCT centers, the Local Review
Committee requested the research team remove all ques-
tions pertaining to drug use behaviors as well as other ac-
tivities of the CCT participants while in CCT centers. This
was the only substantial request. This had a significant im-
pact on the study because data regarding drug use behav-
iors during the two-year period of CCT rehabilitation
were not collected. This requirement necessitated the use
of proxy data (discussed below). While the use of proxy
data for estimating drug use behaviors is less desirable, the
trade-off was needed for the study to proceed and for the
continued support of the local government. This was not
only for the implementation of the study but also for the
support for dissemination of the study findings.
Recruitment challenges
All CCT participants who were released from the three
CCT centers during January-November 2013 were
invited to take part in the study. In order to recruit the
208 CCT participants, 550 invitation letters were sent to
eligible CCT participants by the CCT center staff. As it
would be unethical for the researchers to be aware of
the names of the CCT participants without their agree-
ment, the researchers provided the invitation letters to
the CCT center staff to distribute. Approximately 30% of
the letters were returned due to unidentifiable postal ad-
dress. Therefore, two additional recruitment strategies
were introduced: (1) referral by CCT-released partici-
pants who had already enrolled in the study; and (2) re-
ferral through the peer educators’ network. Specifically,
at the end of each interview with a CCT-released partici-
pant, the interviewer provided three copies of the infor-
mation leaflet and asked them to assist by providing the
leaflet to people who they believed would be eligible for
the study. The leaflet indicated that eligible participants
were required to show the official certificate of treat-
ment completion. The research field investigator also
contacted the peer education program supported by
FHI360 to talk to 16 peer educators and ask them to as-
sist by delivering the information leaflet to people they
identified as eligible for the study. The proportion of en-
rolled participants as a result of being referred by these
additional means was 29.8% (62 out of 208).
The final sample for the CCT arm at study commence-
ment was 208 (54% of the CCT exits). The non-
participation rate was largely due to an inability to con-
tact potential participants. The sample size required for
sufficient statistical power was achieved for CCT partici-
pants and exceeded for MMT participants (n = 384).
This demonstrated the feasibility of recruiting voluntary
participation in a drug treatment study, including vul-
nerable groups who had been involuntarily detained for
2 years even though they may rightly have been suspi-
cious of any government-associated research.
The intent was to collect data from both groups across
five time-points (baseline, two years after treatment
commencement, then 3, 6, and 12 months after the ini-
tial two years). A substantial delay in obtaining political
endorsement from the Hai Phong City Government
meant there were variations between the original
planned timeline and the actual recruitment and follow-
up interviews. Specifically, the time between the first
follow-up interview (T1) and the second follow-up inter-
view (T2) for the MMT group was 19 months (the time
between the end of the previous MMT study and the be-
ginning of the current study) while it was 3 months for
the CCT group. For the CCT group, there was an aver-
age of 4 months between the time of release from the
CCT centers and the T1 interview. Combined, the total
time between baseline and the final follow-up (T4) for
the MMT group was approximately 5 years while it was
3.5 years for CCT group.
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This non-equivalency of time was managed by includ-
ing time as a covariate in the data analysis, allowing the
mixed effects regression modelling to both account for
time as a covariate, and assess the statistical significance
of between group differences in relation to time trends.
This aimed to ensure that the differences in time would
not create a bias in the effectiveness results comparing
two groups.
Despite the marginalized nature of the study partici-
pants, the research team was able to follow-up 80% of
the CCT participants and 78% of the MMT participants
at the end of the study (T4: 12 months post two years
treatment). The follow-up rate at 3 (T2) and 6 (T3)
months for the CCT group was 88 and 83%, respectively
while the follow-up rate at T2 and T3 for the MTT
group was 82 and 80%, respectively. Achieving adequate
follow-up rates with people who are dependent on drugs
and alcohol, particularly participants who are not in
treatment is challenging. Reviews of longitudinal re-
search designs have identified a range of strategies for
maintaining contact with participants and obtaining high
response rates of approximately 70–80% [29]. One of
the strategies involves the collection of detailed locator
information at the start of the study. In this study, at the
baseline interview standardized locator information was
collected including current contact details, names and
contact details of family members or next of kin. This
was reviewed at each follow-up interview. To ensure sys-
tematic implementation of follow-up procedures across
the ten field researchers and to increase the likelihood of
participant follow-up, a “Participant Tracking Protocol”
(see Table 3) was developed with inputs and consensus
from all the ten local researchers. This participatory ap-
proach was used to increase the sense of ownership
thereby increasing the likelihood of them implementing
the protocol.
Data collection challenges
The selection and design of the data collection instru-
ments was limited by the previous MMT study (the
source of the baseline data for the MMT group). The
structured questionnaire was administered by trained in-
terviewers, and asked about the participants’ socio-
demographic information, drug use behaviors, drug-use
related illegal behaviors, blood-borne virus risk behaviors
and overdose experience, for their lifetime, for the pre-
ceding 3 months prior to index treatment, at 2 years
after treatment commencement (from the release date to
the T1 interview date for CCT participants). At the 3-
month (T2), 6-month (T3) and 12-month (T4) inter-
views, the same questions were asked for the period of
the preceding 3 months. At the end of each interview
with CCT participant, a urine drug sample was provided
by the participant for opioid drug screening. The urine
drug test results of MMT participants were retrieved
from their patient records at the MMT clinics. As per
treatment protocol, opioid urine drug testing is carried
out at random for MMT patients on a monthly basis.
The urine drug test results were used to verify the valid-
ity of their self-reported heroin use. For both CCT and
MMT participants, the Alere© MOP One Step Mor-
phine Test was used for urine drug screening. The test
utilizes a monoclonal antibody to selectively detect ele-
vated levels of morphine (the metabolite of heroin) at a
cut-off concentration of 300 ng/mL.
Contrasting data from urine tests for heroin with self-
report of heroin use yielded four possible scenarios: A)
negative urine and negative self-report; B) positive urine
and negative self-report; C) negative urine and positive
self-report; and D) positive urine and positive self-
report. In order to calculate the percentage of concord-
ance between self-report and urine screen results, the
percentage of scenario A and scenario D were added to-
gether. The percent (%) agreement was calculated based
Table 3 Participant tracking protocol
This protocol was developed as a guidance for the study interviewers
in their tracking of the study participant to improve successful follow-
up of the study participants.
1. One month after last interview, call the participant to ensure that
their phone number is still contactable, and remind them of the next
approximate date for the next interview.
o Call the participants: 3 times/3 days/3 different times in the day
(morning, afternoon, evening).
o The first call if the phone rings but not being picked up, send a text
message (introducing name, from Hai Phong Medical University) to
inform will call again.
o If the above don’t work, call next of kin.
2. Call the participant’s family members or friend that are listed in the
consent form the participant provided (if any because some do not
want to provide): for each locator (family member or friend) follow the
same procedures below:
o Call next of kin: 3 times/3 days/3 different times in the day
o If the phone rings but not being picked up, send a text message
(introducing name, from Hai Phong Medical University) to inform will
call again.
→ If (1) and (2) don’t work, move to step 3 and 4 concurrently.
2. Interviewer check the excel administrative list of participants, use
excel search tool to look for participants who have somewhat similar
home addresses (they live near each other), call 1 or 2 participants
whose address is near to ask them to give a message.
3. Use the address they provided in the consent form, send them a
reminder note (using sample/format provided).
4. f they do not return the call after 4 days (from the send date of the
reminder note), use the address they provided to look for their home to
see if they still live there.
5. Two months after the interview, repeat the steps from 1 to 5;
6. If still not successful, wait until 7 days before the scheduled next
interview, repeat the steps from 1 to 5;
7. If still not successful, skip this interview (consider missing of 1 wave);
8. Repeat steps from 1 to 5 for the future waves;
Note:
Each interviewer has been provided with a tracking book with tables laid out,
please remember to take notes of all information related to dates of phone
calls, dates of sending text messages, dates of sending letters, dates of home
visits and other related information that are helpful to assist successful
tracking of participants
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on the number of valid cases, i.e., cases that were not
lost-to-follow-up at the relevant time-point.
For CCT participants, the overall concordance be-
tween self-report and urine screen ranged from 80–86%
from T1 to T4 (Table 4) (baseline drug screening results
were not available for CCT participants because the first
interviews were conducted at T1 and self-report data on
baseline behaviors were collected retrospectively). For
MMT participants, the overall concordance between
self-report and urine screen ranged from 82–88% from
T1 to T4 (Table 5).
Overall, the concordance between self-reported heroin
use and results from urine drug screens was high for
both groups and suggested that the participants of both
groups reported their heroin use accurately.
As noted above, it was not possible to collect data on
drug-using behaviors of the CCT participants while be-
ing in CCT centers. For this study, the primary outcome
was the number of drug-free days over 3 years (two
years in CCT centers plus 1 year in the community for
CCT participants). Therefore, the number of drug-free
days for the two year stays in CCT centers needed to be
estimated. Proxy data of drug from behaviors reported
among prison populations was identified and used be-
cause the conditions under which CCT centers operate
are similar to the conditions under which international
prisons operate, such as security, discipline, no-tolerance
of illicit drug use policy. As such, the proxy data were
derived from the reported prevalence and frequency of
illicit drug use among prison populations in other coun-
tries [30–35]. Specifically, the six referenced studies pro-
vided evidence that the illicit drug use prevalence among
drug-using prison inmates ranged from 31 to 74% and
the frequency of use ranged from 1 to 8 days in the last
30 days. Derivation of a number that could be represen-
tative of these studies was impossible. Therefore, a
decision was made to use a generalized average of 26
drug-free days out of 30 for imputation (for the 67% of
the CCT participants who reported drug use at T1) for
their 2-year stay in the CCT centers. The remaining 33%
Table 4 Agreement of self-reported heroin use and urine drug
screens: CCT participants
Urine drug screen results
Self-report Negative Time-points Negative Positive Totals
A B



















































*The percentage (%) of agreement was calculated based on the number of valid
cases, i.e., cases that were not lost-to-follow-up at the corresponding time-point
**The concordance rates were calculated by dividing the number of cases with
responses matched by the number of valid cases
Concordance of agreement = A + D:
T1 = 29% + 54% = 83%
T2 = 31% + 55% = 86%
T3 = 27% + 53% = 80%
T4 = 33% + 51% = 84%
Table 5 Agreement of self-reported heroin use and urine drug
screens: MMT participants
Urine drug screen results































































*The percentage (%) of agreement was calculated based on the number of valid
cases, i.e., cases that were not lost-to-follow-up at the corresponding time-point
**The concordance rates were calculated by dividing the number of cases with
responses matched by the number of valid cases
Concordance of agreement = A + D:
Baseline = 1% + 96% = 97%
T1 = 77% + 5% = 82%
T2 = 80% + 2% = 82%
T3 = 85% + 2% = 87%
T4 = 87% + 1% = 88%
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of the CCT participants did not report illicit drug use at
T1, hence were assumed to be less likely to have used
illicit drugs while in the CCT. It was believed that this
assumption was reasonable because drug use occurrence
has been reported in the Vietnam CCTs [36, 37].
Even though quality-adjusted life years (QALYs) is a
critical measure of effectiveness in economic evaluations,
it was not possible to use QALYs as an outcome meas-
ure for this study. The reason was because by guideline,
the tools used to measure quality of life (EQ-5D, SF-6D,
HUI) apply to a respondent’s immediate situation. They
are not intended to be used to summarize the health sta-
tus recall over the preceding weeks, months, or in our
case, years. The design of this study required recall of
data up to 24 months (for CCT participants). Therefore,
estimating the change in QALYs of the participants was
not technically possible.
Sources and quantification of effectiveness data
Table 6 provides information on the six outcome mea-
sures for the comparison of effectiveness, with details on
where each of the outcome measures was sourced from
and how each of them was quantified into values that
were later used for the data analysis.
Table 7 provides information on two outcome mea-
sures for the comparison of cost-effectiveness with de-
tails on how each of them was quantified into values
that were used for the data analysis.
Sources and quantification of cost data
The perspective taken for the cost-effectiveness analysis
(CEA) was that of the treatment sector. The average
program costs (total program costs for each MMT clinic
and CCT center divided by the number of participants)
were added to the individual-specific participant costs to
derive an individual-specific total cost. Although both
participant and program costs were included, it was not
a full societal perspective as it did not include other
health care or criminal justice costs. Program costs in-
cluded all costs required for the functioning of a CCT
center or a MMT clinic, except for the cost of land. Par-
ticipant personal costs included costs paid by the partici-
pants and the opportunity costs (travel costs and loss of
productivity) of attending treatment. Loss of productivity
was calculated using the reported times for both groups
and the individual-specific monthly wage. MMT pro-
gram cost data came from: (1) a previous MMT cost
study that provided 2009 program costs [38]; and (2) a
MMT program 2013 expenditure report provided by the
Hai Phong City Department of Health; and (3)
individual-specific methadone doses from which the
individual-specific methadone syrup cost was calculated.
CCT program costs were 2010, 2011, and 2012 financial
data, provided by three CCT centers through a modified
DATCAP questionnaire [39]. A detailed description of
the cost components and the sources of data are pre-
sented in Table 8. The average annual MMT and CCT
program costs were averaged across the different years,
Table 6 Six outcomes measures for comparison of effectiveness: sources and quantification
Outcome measures How the outcome measures were sourced and quantified
Comparison of effectiveness
Heroin use Based on self-reported heroin use at each of the five time-points. The question was ‘During the last 3 months,
did you use heroin?’ The answer was ‘Yes’ or ‘No’ (dichotomous outcome variable created in the data set with
Yes = 1 and No = 0). Results of urine drug screening were used to validate self-reported heroin use.
Drug-free days (in the preceding
30 days)
The question asked was ‘During the previous 30 days, on average, how many days did you NOT use any illicit




A list of 6 questions about drug-use related illegal behaviors was asked; each focused on a type of illegal behavior:
a) Using force to get money from other people; b) Fraud; c) Theft; d) Robbery; e) Illicit drug dealing; and f) Assault,
physical flight to get money to buy illicit drugs. A dichotomous variable (Yes/No) was created for this outcome
measure with all illegal behaviors combined.
Drug-used related BBV risk
behaviors
The BBV-TRAQ-SV [46] was used to create data for this outcome measure. Answers to all questions were counted
and a single summary score was calculated.
Overdose incident The question was ‘Did you experience any overdose incident during the previous 3 months?’ A dichotomous
outcome variable was created with Yes = 1 and No = 0.
Monthly drug spending Answers to 4 questions were used to calculate the value for this outcome variable:
‘The number of days using illicit drugs monthly?’
‘List of the three drugs that you used the most frequently during the last 3 months?’
‘For each of the three drugs, how much money did you spend for one time of use?’
‘What was the frequency of use for each of the 3 drugs?’
The following formula was used to calculate the amount of monthly drug spending for each drug:
MonthlySpending = (NumberOfDaysUse*DrugDailyFrequency*AmountSpent) + (DrugWeeklyFrequency*4
(weeks)*AmountSpent) + (DrugMonthlyFrequency*AmountSpent)
The amount of monthly spending for all three drugs were added together and the value formed a continuous
outcome variable.
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after adjustment for inflation using the 2013 general
Consumer Price Index for Vietnamese Dong (VND) [40]
as well as adjusting for participant drop-out at each
time-point.
For this study, it was not possible to estimate the land
cost of CCT centers which would be substantial given
that CCT centers use a large area of agricultural or for-
estry land. Inclusion of land costs in the study required
complicated assessment of land value (with specific pro-
cedures required by the Vietnam Ministry of Finance)
that was not feasible within the study framework and re-
sources. In addition, the governments accounting at the
time of the study (and also at the present time) excluded
the land value from the costs of public services. The
study, therefore, excluded the land cost from the data
collection. Similarly the value of production from this
land was not included. Data on land and facilities of
MMT clinics were available but were not used because
land costs of CCT centers were not available.
Program and participant personal costs were calcu-
lated for one year before combining these two compo-
nents to derive 1-year total average cost. Because the
time horizon of the cost-effectiveness analysis was
3 years, the 3-year average total costs were based on the
1-year average total costs and the individual-specific
number of years in treatment. Here, we faced a challenge
pertaining to the time in-equivalence of the two treat-
ment modalities, in that the MMT treatment was an on-
Table 7 Two outcomes measures for comparison of cost-effectiveness: sources and quantification
Outcome measures How the outcome measures were sourced and quantified
Comparison of cost-effectiveness
Heroin abstinence The mechanics of the transfer of the results from the effectiveness analysis over to the CEA for ‘heroin abstinence’
outcome followed three steps:
Step 1: The mixed effects regression analysis conducted on ‘heroin use’ produced individual-specific predicted values
pertaining to the probability of ‘heroin use’ at each of the five time-points.
Step 2: The individual-specific predicted values of the probability of ‘heroin use’ at the final time-point was selected,
and then manually reversed to become the probability of ‘heroin abstinence’. For example, if the probability of ‘heroin
use’ of one participant was 0.78, the probability of ‘heroin abstinence’ of this participant would be 1–0.78 = 0.22.
Step 3: These individual-specific predicted values of the probability of ‘heroin abstinence’ were then used for estimating
the ICER together with the cost data.
Drug-free days (over
36 months)
The mechanics of the transfer of the results from the effectiveness analysis over to the CEA for DFDs followed three
steps:
Step 1: The mixed effects regression analysis conducted on DFDs (in the preceding 30 days)’ produced the individual-
specific predicted values for each of the five time-points.
Step 2: Using these individual-specific predicted values of all five time-points to calculate the aggregated value over
36 months, using the formula described above.
Step 3: The individual-specific aggregated values for the DFDs (over 36 months)’ were then used for estimating the
ICER together with the cost data.
Table 8 Cost components of MMT and CCT
Program costs Participant costs
For MMT:
Recurrent costs: variable costs (salary for staff, methadone, urine tests
and consumables), and fixed costs (site operation and maintenance,
medication import and distribution)
Capital costsa:
Buildings and equipment/vehicles (10% depreciated value over 10 years)
Data sources:
+ Secondary data of the 2009 costing study
+2013 expenditure data provided by Hai Phong City Department of
Health
Cost of treatment: zero because the treatment was free to the participants
Opportunity costs:
Costs of travel time to MMT clinic on a daily basis including waiting time
Cost of petrol for travel to the MMT clinic on a daily basis
Data sources:
+ Data collected through the modified DATCAP questionnaire –
Outpatient version, used once for the baseline interview
For CCT:
Recurrent costs: variable costs (salary for staff, medicines, biological tests
and consumables), and fixed costs (center operation and maintenance)
Capital costs: a
Buildings and equipment/vehicles (10% depreciated value over 10 years)
Data sources:
+ Data collected through the structured questionnaire that was based
on the framework of the DATCAP questionnaire–Program version
Cost of treatment during the 2 years in CCT centers:
+ Rehabilitation costs paid by participants to the centers
+ Costs of food and other supplies provided by families to the participants
on a monthly basis
Opportunity costs:
Loss of income due to 2-year placement in CCT centers (based on self-
report monthly income and employment status at 3-month prior to CCT
placement)
Data sources:
+ Questions asked once, included in the outcome questionnaire for the
baseline interview
aValue of MMT clinics land and CCT centers land was not collected (to be discussed in the Discussion section)
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going intervention while the CCT rehabilitation was
time-limited for 2 years, with no costs incurred in the
third year. To resolve this we used a pragmatic strategy.
For MMT, the average three-year program costs were
calculated by multiplying the average annual program
costs by three (with adjustment for drop-out). For CCT,
the average 3-year program costs were calculated by
multiplying the average annual program costs by two.
Every CCT participant, by law, completed the 2-year
CCT compulsory treatment therefore adjustment for
drop-out was not required.
Discussion
Science and politics in study design and implementation
We have demonstrated that conducting research around
compulsory treatment in a non-democratic society is
feasible. However, the study confronted a number of eth-
ical, logistical, methodological, and political challenges,
which affected several aspects of the study.
In 2011, Human Rights Watch criticized the Vietnamese
government and many international aid organizations for
supporting the CCT center system in Vietnam and
claimed that the system “infringes on human rights stan-
dards”. The criticism was voiced through the release of a
report titled “The Rehab Archipelago: Forced Labor and
Other Abuses in Drug Detention Centers in Southern
Vietnam”, providing evidence on inhumane treatment and
labour abuse of people who use drugs in many CCT cen-
ters in the south of Vietnam [18]. Being publicly criticized
in various international fora, international aid organiza-
tions were forced to devise strategies to disengage from
supporting the CCT centers [28]. Similar to other
Southeast Asian governments who have also been criti-
cized on this issue, the Vietnamese government exhibited
a diplomatic attitude in handling human rights criticisms.
Yet, they also expressed their confusion about why com-
pulsory treatment in Vietnam was criticized when it was
seen as acceptable in developed countries and when
UNODC in their endorsed principles of treatment claimed
that “compulsory treatment could be effective” [41]. Fur-
thermore the INCB had called on Vietnam to “reinforce
and support existing facilities” [42]. As such, the debates
around the ethics of compulsory centers appear to see no
resolution in sight [14, 15, 43].
Perceptions about the impact of the criticisms by hu-
man rights organizations towards the Vietnamese gov-
ernment (and other Southeast Asian governments more
broadly) pertaining to the CCT centers approach have
varied. On the one hand, the human rights arguments
have been perceived to be confusing, unhelpful and at
times counter-productive because different societies and
cultures define human rights differently and Western in-
terpretations of human rights are viewed by Asian
leaders as unpalatable [44]. On the other hand the
efforts by human rights organizations have been per-
ceived as achieving their goals to a substantial extent.
While there may have been no direct impact on the
Vietnamese government, they have helped raise aware-
ness among international aid organizations, including
international donors and UN agencies. It has demanded
a rethink and more sophisticated responses by inter-
national aid organizations. Subsequent actions by inter-
national agencies took various forms: a) engaging in a
more direct dialogue with the government on shifting
away from compulsory centers approach (conversations
which were often avoided in the past); and b) withdraw-
ing funding from CCT centers because any support of
the system was considered as legitimizing its continu-
ance. Five years on from the release of the Human Right
Watch’s report, the number of CCT centers in Vietnam
had not changed. But the Vietnamese government intro-
duced several legal documents that made it harder to
send people who use drugs to CCT centers. As a conse-
quence, many CCT centers have much fewer residents
than the designed capacity.
In the meantime, a more effective approach over and
above human rights arguments is the economic argu-
ment (i.e., scientific evidence from an economic evalu-
ation), which engaged the Vietnamese government with
the aim of practical change. An economic argument is
believed to be more straightforward, less aggressive and
therefore more likely to be considered by Vietnamese
leaders. However, at the inception of this study, more
than once, the Vietnamese research team (more specific-
ally TV) was challenged by various staffers of inter-
national aid organizations in Vietnam about what
strategies should be in place if the results of such an
economic evaluation showed that CCT was more effect-
ive or more cost-effective than MMT. As such, there
were two levels of risk in conducting this study: the risk
involved with its implementation and the risk pertaining
to what should be done if unexpected results were
realized.
Notwithstanding the risk of the possibility of unex-
pected results, this study faced challenges in getting pol-
itical endorsement for its implementation in the
territory of Hai Phong City, especially when the approval
was sought 1 year after the release of the Human Rights
Watch report. It took 2 years for the political endorse-
ment to be finally granted (in February 2012). However,
in July 2012 there was a change in the leadership of the
Department of Labor, Invalids and Social Affairs
(DOLISA), the department in charge of the CCT centers.
This required a new approval, which was not granted
until June 2013. The new approval was possible at the
cost of a series of negotiations and compromises and the
cost of a substantial delay of implementation (approxi-
mately 12 months). The compromises included a)
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removal of questions on drug-using behaviors of CCT
participants while being in CCT centers and b) constraints
on location where interviews with CCT participants could
be conducted. At one point it was believed that the new
approval would not be possible. The primary reason for
the uncertainty was because the Hai Phong City govern-
ment was concerned about the possibility that research
implemented by international organizations could pose a
political threat through the ‘exposure of information’
about how people who use illicit drugs are treated in the
CCT centers. Because of this concern, the new DOLISA
leader requested the research team submit the study
protocol, the questionnaires and all related recruitment
materials for his review and endorsement, in consultation
with other relevant government departments (the Depart-
ment of Police, the People’s Committee, the Department
of External Affairs).
Navigation between science and politics was required
for the study to move forward. Similar to the random-
ized controlled trial of heroin-assisted treatment in
Canada conducted in 2009 [45], political considerations
influenced study design to some degree. For this study
conclusions have been drawn using proxy data. In
addition, interviews of participants were only allowed in
one location to enable monitoring of the research activ-
ities by the local government. Without this constraint,
interviews could also have been conducted in the neigh-
borhoods near the homes of study participants. This
may have further increased the follow-up rates (notwith-
standing the high rates achieved: 80% for CCT partici-
pants), hence increasing the level of confidence in the
study conclusions. Last but not least, the need for a
renewed political approval following a change in the
leadership of Hai Phong City DOLISA came at the cost
of a substantial delay for the study. This caused varia-
tions between the original design and the actual recruit-
ment and participant interview timelines.
As mentioned previously, the ultimate goal of conduct-
ing this research was to generate evidence to support dia-
logue for drug policy change in Vietnam. The main results
of the cost-effectiveness analysis demonstrated that MMT
is not only more effective but also less expensive than
CCT in achieving additional drug-free days [26]. The con-
clusiveness of the study findings was critical for gaining
acceptance from the political audience who were the tar-
geted end-users of this study. In April 2015, three meet-
ings were organized by FHI360 to disseminate the results
of the study. The first meeting was for all the relevant gov-
ernment agencies in Hai Phong City. The second meeting
was for the international agencies who work on drug de-
pendence treatment and HIV in Vietnam and the third
meeting was for the Advisory Board, whose members are
retired ministers, and whom provide advice to the Deputy
Prime Minister on drug policy, civil society organizations
and the representatives of three key ministries (Ministry
of Labor, Invalids and Social Affairs, Ministry of Health
and Ministry of Public Security). In all three meetings, the
audience was not surprised by the findings of the study.
Despite some discussion of the limitations of the study
(non-randomization and time-frame), the study findings
were well-received. Anecdotally, for a long time, there had
been a belief that MMT is likely to be less costly and more
effective than CCT. But there had been no empirical data
to substantiate this belief. Without the confirmation of
empirical data, the work of policy advocacy (of both inter-
national agencies and government agencies) for evidence-
informed policy-making had been extremely challenging.
The process has resulted in the official publication and
dissemination of the study findings report (in both English
and Vietnamese). In July 2015, the Advisory Board took
ownership of the study and presented the study findings
to the Deputy Prime Minister. The outcome was a letter
from the Chairman of the Office of the Government giv-
ing authorization to the Advisory Board to disseminate
the findings of the study via a variety of communication
media, including via official visits to the provinces and via
the official website of the Office of the Government
“Tieng Chuong” (The Bell) (ref Letter 6021/VPCP-KHVX
dated 31 July 2015).
Nevertheless, it would be naïve to think that a single
study could lead to significant change in drug policy-
making. Rather, policy change occurs through the
culmination of efforts and strategies, from a range of dif-
ferent actors across many years of advocacy work. If this
study had never been conducted, positive change in
Vietnam would still have occurred. However, the find-
ings of this study assisted by facilitating more evidence
based conversations between advocacy agencies and gov-
ernment decision-makers, hence speeding up the
process of change. Politicians and government bureau-
crats who used to be ambivalent might be able to recon-
sider their position. Members of the Advisory Board to
the Deputy Prime Minister have taken ownership of the
study findings in their conversations with leadership of
local jurisdictions. For Vietnam, the road from policy to
implementation will be long. Progress is likely to be
challenged by existing laws and policies, the lack of
skilled human resources and infrastructure to rapidly es-
tablish evidence-based community treatment in place of
these CCT centers, the pervasive stigmatization of
people who use drugs and the ongoing tension between
the abstinence-based model of treatment as compared to
harm reduction approaches.
Lessons learned
We have learned much about the successes and chal-
lenges of conducting research around compulsory drug
treatment in Vietnam. On the positive side, we have
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demonstrated that conducting research in this topic is
feasible, largely due to the high levels of diligence and
perseverance from the Vietnam research team leaders.
But it was not only persistence and perseverance that
was needed. The political endorsement was possible due
to a combination of factors: the progressiveness of Hai
Phong leadership (notwithstanding the delay in decision-
making on granting final approval for the study), the
local government’s trust in FHI360 (which implements
the biggest US-funded HIV program in Vietnam), and
FHI360’s 10-year financial and technical assistance to
Hai Phong City for the implementation of a comprehen-
sive HIV and drug dependence treatment program.
Without any of the above factors, the conduct of this
study may have been impossible.
Methodologically, some of the most important lessons
concern the strategies for recruitment of participants
and the independence of the research and clinical teams.
An active recruitment carried out by well-trained local
researchers and peer educators/outreach workers with
good ties to the community that serves the target popu-
lation was crucial to recruiting the needed number of
CCT participants. Despite the marginalized nature of
the study participants, the research team was able to
follow-up 80% of the CCT participants and 78% of the
MMT participants.
Conclusions
Research on compulsory drug dependence treatment is
feasible but politically challenging and requires naviga-
tion between science and politics. This paper shares les-
sons learned and offers assistance for the design and
conduct of future research in this challenging topic in
other Southeast Asian countries. The study findings have
been and will continue to be used for drug policy advo-
cacy in Vietnam [26]. Scientific evidence is only one type
of information available to politicians. Information, in-
cluding scientific and other types, has to compete with
ideologies and self-interests to gain primacy in policy
making. Evidence can make a difference, particularly in
countries that take pragmatic approaches to health prob-
lems like Vietnam.
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